HeartSciences Inc. (HSCSW)Southlake, United States | NasdaqCM
0.04 USD
|
Hot Take ↕ | Aug. 22, 2026, 2:43 a.m. EDT
The immediate outlook is severely bearish as the stock trades at its 52-week low of $0.042, having recently spiked to $0.07 before collapsing, indicating a failed momentum play. Fundamentally, the business is in freefall with zero revenue growth (-100%), massive losses, and a debt-to-equity ratio exceeding 1,700, signaling a distressed entity rather than a viable investment. There is no dividend income to offset these risks, and the lack of price history prevents any assessment of long-term trends, leaving the security with no safe harbor for capital preservation. |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 1741.417 |
| Revenue per Share | 0.002 |
| Beta | 1.80 |
| Previous Name | Heart Test Laboratories, Inc. |
| Website | https://heartsciences.com |
| Attribute | Value |
|---|---|
| Address1 | 550 Reserve Street |
| Address2 | Suite 360 |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | 1.803 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 0.071 |
| City | Southlake |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.0403 |
| Current Ratio | 0.531 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.0565 |
| Day Low | 0.0403 |
| Debt To Equity | 1,741.417 |
| Display Name | HeartSciences |
| Ebitda | -8,385,076 |
| Ebitda Margins | 0.0 |
| Eps Trailing Twelve Months | -1.094 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.0565 |
| Fifty Two Week High Change | -0.016199999 |
| Fifty Two Week High Change Percent | -0.28672564 |
| Fifty Two Week Low | 0.0403 |
| Fifty Two Week Low Change | 0.0 |
| Fifty Two Week Low Change Percent | 0.0 |
| Fifty Two Week Range | 0.0403 - 0.0565 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,784,295,000,000 |
| Float Shares | 2,723,210 |
| Free Cashflow | -2,870,175 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 14 |
| Fullday Change | 0.0 |
| Fullday Change Percent | 0.0 |
| Fullday Price | 0.0403 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.59064996 |
| Gross Profits | 2,551 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,022-06-15 |
| Language | en-US |
| Long Business Summary | HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas. |
| Long Name | HeartSciences Inc. |
| Market | us_market |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_51732680 |
| Name Change Date | 2,026-08-28 |
| Net Income To Common | -9,141,875 |
| Open | 0.0717 |
| Operating Cashflow | -7,426,707 |
| Operating Margins | -1,947.8738 |
| Phone | 682 237 7781 |
| Prev Name | Heart Test Laboratories, Inc. |
| Previous Close | 0.0403 |
| Price Hint | 4 |
| Price To Book | 0.5676056 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.341 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 0.0565 |
| Regular Market Day Low | 0.0403 |
| Regular Market Day Range | 0.0403 - 0.0565 |
| Regular Market Open | 0.0717 |
| Regular Market Previous Close | 0.0403 |
| Regular Market Price | 0.0403 |
| Regular Market Time | 1,787,860,790 |
| Regular Market Volume | 10 |
| Return On Assets | -1.10864 |
| Return On Equity | -42.39907 |
| Revenue Growth | -1.0 |
| Revenue Per Share | 0.002 |
| Sand P52 Week Change | 0.20504117 |
| Sector | |
| Sector Key | |
| Short Name | Heart Test Laboratories, Inc. W |
| Source Interval | 15 |
| State | TX |
| Symbol | HSCSW |
| Total Cash | 1,656,814 |
| Total Cash Per Share | 0.425 |
| Total Debt | 3,936,647 |
| Total Revenue | 4,319 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.094 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 10 |
| Website | https://heartsciences.com |
| Zip | 76,092 |